Actually about 4 people left over the course of 3 years, and only one of them was working in the lab or the clinic. It's proper practice for around half the Board to roll out every 24 months.
- Forums
- ASX - By Stock
- RAC
- Ann: Impressive Bisantrene Phase 2 AML Clinical Results
Ann: Impressive Bisantrene Phase 2 AML Clinical Results, page-177
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.70 |
Change
0.050(3.03%) |
Mkt cap ! $281.0M |
Open | High | Low | Value | Volume |
$1.65 | $1.70 | $1.65 | $50.65K | 30.58K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 300 | $1.67 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.70 | 200 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 300 | 1.670 |
1 | 1000 | 1.660 |
3 | 3443 | 1.655 |
2 | 7007 | 1.650 |
2 | 6084 | 1.645 |
Price($) | Vol. | No. |
---|---|---|
1.700 | 200 | 1 |
1.710 | 159 | 1 |
1.715 | 1448 | 1 |
1.720 | 545 | 1 |
1.725 | 592 | 1 |
Last trade - 10.27am 04/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online